When.com Web Search

  1. Ads

    related to: how quickly will valtrex work after outbreak coronavirus patients

Search results

  1. Results From The WOW.Com Content Network
  2. Valaciclovir - Wikipedia

    en.wikipedia.org/wiki/Valaciclovir

    Valaciclovir, also spelled valacyclovir, is an antiviral medication used to treat outbreaks of herpes simplex or herpes zoster (shingles). [2] It is also used to prevent cytomegalovirus following a kidney transplant in high risk cases. [2] It is taken by mouth. [2] Common side effects include headache and vomiting. [2]

  3. Treatment and management of COVID-19 - Wikipedia

    en.wikipedia.org/wiki/Treatment_and_management...

    Initial use of ECMO in COVID-19 patients from China early in the pandemic suggested poor outcomes, with less than 90% mortality. [83] In March 2020, the ELSO registry began collecting data on the worldwide use of ECMO for patients with COVID-19 and reporting this data on the ELSO website in real time.

  4. Antiviral drug - Wikipedia

    en.wikipedia.org/wiki/Antiviral_drug

    Immunocompromised patients, more often than immunocompetent patients, hospitalized with pneumonia are at the highest risk of developing oseltamivir resistance during treatment. [41] Subsequent to exposure to someone else with the flu, those who received oseltamivir for "post-exposure prophylaxis" are also at higher risk of resistance.

  5. Coronavirus symptoms start slow, and worsen quickly ... - AOL

    www.aol.com/article/news/2020/03/24/coronavirus...

    As the new coronavirus spreads, doctors are seeing a pattern emerge in the way people are responding to the disease. Coronavirus symptoms start slow, and worsen quickly, doctors say Skip to main ...

  6. Coronavirus can damage the heart, according to a study ... - AOL

    www.aol.com/article/news/2020/07/13/coronavirus...

    The coronavirus can damage the heart, according to a major new study which found abnormalities in the heart function of more than half of patients.

  7. COVID-19 drug development - Wikipedia

    en.wikipedia.org/wiki/COVID-19_drug_development

    Bebtelovimab is a neutralizing human immunoglobulin G1 (IgG1) monoclonal antibody, isolated from a patient who has recovered from the Coronavirus disease 2019 (COVID-19), directed against the spike (S) protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19.

  8. RECOVERY Trial - Wikipedia

    en.wikipedia.org/wiki/Recovery_trial

    Tocilizumab significantly reduces the risk of death when given to hospitalised patients with severe COVID-19. 2022 patients allocated to Tocilizumab were compared to 2094 who received standard hospital care. "596 (29%) of the patients in the tocilizumab group died within 28 days compared with 694 (33%) patients in the usual care group (rate ...

  9. Public health mitigation of COVID-19 - Wikipedia

    en.wikipedia.org/wiki/Public_health_mitigation...

    An army-constructed field hospital outside Östra sjukhuset (Eastern hospital) in Gothenburg, Sweden, contains temporary intensive care units for COVID-19 patients. Increasing capacity and adapting healthcare for the needs of COVID-19 patients is described by the WHO as a fundamental outbreak response measure. [ 52 ]